Latest Breaking News On - Partner takeda to develop - Page 1 : comparemela.com

Investegate announcements from Heidelberg Pharma AG, Heidelberg Pharma Announces Conclusion of License Agreement with Partner Takeda To Develop an Antibody Targeted Amanitin Conjugate

Sylvia wimmerHeidelberg pharmaMc servicesCorporate communicationsFrankfurt stock exchangeHeidelberg pharma research gmbDistribution servicesPharma announces conclusionLicense agreementPartner takeda to developAntibody targeted amanitinHeidelberg pharma research gmbhAntibody targeted amanitin conjugateAntibody drug conjugatesHeidelberg pharma researchRegulatory announcements